[Immediate results of sarcolysine therapy of patients with malignant tumors of the ovaries].
The data on 41 patients with epithelial malignant tumors of the ovaries, who received sarcolysin at different stages of combined treatment, were analyzed. The following factors of therapeutic effect of sarcolysin were established: age of 41-50 years, presence of ascites, administration by two routes--intravenously and intracavitarily and a total dose in excess of 160 mg. Still another factor is contributed by the extent of surgical procedure carried out as primary treatment.
D000230:Adenocarcinoma / Q000188:drug therapy*; D000328:Adult; D003536:Cystadenocarcinoma / Q000188:drug therapy*; D004715:Endometriosis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008558:Melphalan / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy*
D008558:Melphalan
Neposredstvennye rezul'taty lecheniia sarkolizinom bol'nykh zlokachestvennymi opukholiami iaichnikov.